Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

PPI use not linked to increased risk of developing dementia

Proton pump inhibitors (PPIs) are medicines commonly prescribed to treat acid-related digestive problems, including gastroesophageal reflux disease (or GERD).

21 Nov 2017

‘Chemo brain’ may start as tumors form and develop, suggests study

The memory and thinking problems experienced by cancer survivors, known as "chemo brain" or "chemo fog," are not just the result of chemotherapy treatment, they may start as tumors form and develop, suggests a Baycrest-led study.

21 Nov 2017

Sensors for identifying biomarkers could help detect myriad of diseases at early stages

Purdue University researchers have found a method of identifying biological markers in small amounts of blood that they believe could be used to detect a myriad of diseases, infections and different medical conditions at early stages.

21 Nov 2017

Benzodiazepines linked to increased risk of death among Alzheimer’s disease patients

Benzodiazepine and related drug use is associated with a 40 per cent increase in mortality among persons with Alzheimer's disease, according to a new study from the University of Eastern Finland. The findings were published in the International Journal of Geriatric Psychiatry.

20 Nov 2017

Researchers uncover mechanism that contributes to patterns of degeneration in AD

Alzheimer's disease (AD) is known to cause memory loss and cognitive decline, but other functions of the brain can remain intact.

17 Nov 2017

Experts identify mental exercise program that can reduce risk of dementia

Aging research specialists have identified, for the first time, a form of mental exercise that can reduce the risk of dementia.

17 Nov 2017

Brain astrocytes could play key role in pathogenesis of Alzheimer's disease

Astrocytes, the supporting cells of the brain, could play a significant role in the pathogenesis of Alzheimer's disease (AD), according to a new study from the University of Eastern Finland. This is the first time researchers discovered a direct association between astrocytes and AD. Published in Stem Cell Reports, the study investigated the brain cell function of familial AD patients by using stem cell technologies.

17 Nov 2017

Discovery of natural molecule could lead to effective treatments for gum disease and atherosclerosis

Resolvin E1, a molecule produced naturally in the body from an omega -3 fish oil, topically applied on gum tissues not only prevents and treats gum disease as previously shown (Hasturk et al 2006 and 2007), but also decreases the likelihood for advanced arterial atherosclerotic plaques to rupture and form a dangerous thrombus or blood clot.

16 Nov 2017

Computerized speed of processing training results in decreased risk of dementia

Computerized brain-training is now the first intervention of any kind to reduce the risk of dementia among older adults.

16 Nov 2017

Virtual reality training may be effective alternative to standard therapy after stroke

Using virtual reality therapy to improve arm and hand movement after a stroke is equally as effective as regular therapy, according to a study published in the November 15, 2017, online issue of Neurology, the medical journal of the American Academy of Neurology.

16 Nov 2017

New drug shows promise in mouse model of autism disorder

Scientists have performed a successful test of a possible new drug in a mouse model of an autism disorder. The candidate drug, called NitroSynapsin, largely corrected electrical, behavioral and brain abnormalities in the mice.

14 Nov 2017

Taking a page from pharma’s playbook to fight the opioid crisis

Dr. Mary Meengs remembers the days, a couple of decades ago, when pharmaceutical salespeople would drop into her family practice in Chicago, eager to catch a moment between patients so they could pitch her a new drug.

14 Nov 2017

Scientists identify critical player in Alzheimer's disease pathogenesis

Scientists at Sanford Burnham Prebys Medical Discovery Institute have shown that a protein called membralin is critical for keeping Alzheimer's disease pathology in check.

14 Nov 2017

Heart attack linked to increased risk of developing vascular dementia

Heart attack increased the risk of vascular dementia by 35 percent, and the risk remains elevated for up to 35 years after the heart attack.

13 Nov 2017

Scientists develop novel mouse model to capture pathology of sporadic ALS and FTD

Neurodegenerative diseases are incurable and debilitating conditions that result in progressive degeneration and death of nerve cells, which leads to problems with movement or mental functioning. Examples include Alzheimer's, Parkinson's, amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD).

13 Nov 2017

Researchers find distinct molecular signatures in chronic fatigue syndrome and Gulf War Illness

Researchers at Georgetown University Medical Center have found distinct molecular signatures in two brain disorders long thought to be psychological in origin -- chronic fatigue syndrome (CFS) and Gulf War Illness (GWI).

10 Nov 2017

New biomarker could lead to early detection of Alzheimer's disease

Researchers at Sanford Burnham Prebys Medical Discovery Institute have identified a peptide that could lead to the early detection of Alzheimer's disease (AD).

10 Nov 2017

OSA may put elderly people at increased risk of developing Alzheimer's disease

Obstructive sleep apnea (OSA) may put elderly people at greater risk of developing Alzheimer's disease (AD), according to new research published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

10 Nov 2017

RUDN chemists obtain unusual organic compounds that could be used in pharmaceutics

Researchers from RUDN University conducted an effective three-component reaction, obtaining unusual organic compounds. The latter are structurally similar to a number of biologically active compounds - which makes it possible to use them in pharmaceutics.

9 Nov 2017

Mushrooms have high amounts of antioxidants that may help with anti-aging treatments

Mushrooms may contain unusually high amounts of two antioxidants that some scientists suggest could help fight aging and bolster health, according to a team of Penn State researchers.

9 Nov 2017

Alzheimer's Disease News and Research

Further Reading

PPI use not linked to increased risk of developing dementia

‘Chemo brain’ may start as tumors form and develop, suggests study

Sensors for identifying biomarkers could help detect myriad of diseases at early stages

Benzodiazepines linked to increased risk of death among Alzheimer’s disease patients

Researchers uncover mechanism that contributes to patterns of degeneration in AD

Experts identify mental exercise program that can reduce risk of dementia

Brain astrocytes could play key role in pathogenesis of Alzheimer's disease

Discovery of natural molecule could lead to effective treatments for gum disease and atherosclerosis

Computerized speed of processing training results in decreased risk of dementia

Virtual reality training may be effective alternative to standard therapy after stroke

New drug shows promise in mouse model of autism disorder

Taking a page from pharma’s playbook to fight the opioid crisis

Scientists identify critical player in Alzheimer's disease pathogenesis

Heart attack linked to increased risk of developing vascular dementia

Scientists develop novel mouse model to capture pathology of sporadic ALS and FTD

Researchers find distinct molecular signatures in chronic fatigue syndrome and Gulf War Illness

New biomarker could lead to early detection of Alzheimer's disease

OSA may put elderly people at increased risk of developing Alzheimer's disease

RUDN chemists obtain unusual organic compounds that could be used in pharmaceutics

Mushrooms have high amounts of antioxidants that may help with anti-aging treatments

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News